Publications by authors named "Paolo Carta"

Claim this Profile
T
Ten-year trend of rituximab use for hematological malignancies: a multiregional real-world study using the Italian VALORE distributed database network.
Federica Soardo, Andrea Spini, Luca L'Abbate, Chiara Bellitto, Giorgia Pellegrini, Paolo Carta

Expert Opin Biol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single and multiple switches, swap and retransitioning among 28,073 biological drug users with inflammatory bowel diseases: results from the Italian VALORE network.
Giorgia Pellegrini, Andrea Spini, Chiara Bellitto, Luca L'Abbate, Ylenia Ingrasciotta, Paolo Carta

Therap Adv Gastroenterol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trajectories of Adherence to Biologics in Patients With Inflammatory Bowel Diseases: A Large-Scale Multi-Regional Italian Study Through the VALORE Distributed Database.
Sabrina Giometto, Andrea Spini, Giorgia Pellegrini, Ylenia Ingrasciotta, Chiara Bellitto, Paolo Carta

Pharmacoepidemiol Drug Saf· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trend in the use of biological drugs in pediatric patients with immune-mediated inflammatory diseases: Insight from the large-scale Italian VALORE project.
Chiara Bellitto, Ylenia Ingrasciotta, Federica Soardo, Andrea Spini, Luca L'Abbate, Paolo Carta

Pharmacol Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of Biological Drug Use in Older Patients with Immune-Mediated Inflammatory Diseases: Results from the Large-Scale Italian VALORE Distributed Database Network.
Federica Soardo, Andrea Spini, Giorgia Pellegrini, Giorgio Costa, Clément Mathieu, Paolo Carta

BioDrugs· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trajectories of biologic drug use before, during and after pregnancy: an Italian cohort study from the VALORE project.
Sara Lopes, Michela Servadio, Andrea Spini, Luca L'Abbate, Ylenia Ingrasciotta, Paolo Carta

Expert Opin Biol Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network.
Andrea Spini, Giorgia Pellegrini, Ylenia Ingrasciotta, Luca L'Abbate, Chiara Bellitto, Paolo Carta

Expert Opin Biol Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal and spatial variability of immunosuppressive therapies in transplant patients: An observational study in Italy.
Maria Lucia Marino, Alessandro C Rosa, Marco Finocchietti, Arianna Bellini, Francesca R Poggi, Paolo Carta

Front Transplant· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Italian multicentre distributed data research network to study the use, effectiveness, and safety of immunosuppressive drugs in transplant patients: Framework and perspectives of the CESIT project.
Valeria Belleudi, Alessandro C Rosa, Marco Finocchietti, Francesca R Poggi, Maria Lucia Marino, Paolo Carta

Front Pharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-human leukocyte antigen DQ antibodies in renal transplantation: Are we underestimating the most frequent donor specific alloantibodies?
Paolo Carta, Lorenzo Di Maria, Leonardo Caroti, Elisa Buti, Giulia Antognoli

Transplant Rev (Orlando)· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttransplant outcome of atypical haemolytic uraemic syndrome in a patient with thrombomodulin mutation: a case without recurrence.
Leonardo Caroti, Lorenzo Di Maria, Paolo Carta, Luciano Moscarelli, Calogero Cirami

Clin Kidney J· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unplanned pregnancies in kidney transplanted patients treated with everolimus: three case reports.
Paolo Carta, Maria Zanazzi, Enrico Eugenio Minetti

Transpl Int· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuation versus discontinuation of lithium during pregnancy: a retrospective case series.
Valeria Deiana, Caterina Chillotti, Mirko Manchia, Paolo Carta, Alberto Bocchetta

J Clin Psychopharmacol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience.
Luciano Moscarelli, Leonardo Caroti, Giulia Antognoli, Maria Zanazzi, Lorenzo Di Maria, Paolo Carta

Clin Transplant· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the pre-transplant histological score on 3-year graft outcomes of kidneys from marginal donors: a single-centre study.
Paolo Carta, Maria Zanazzi, Leonardo Caroti, Elisa Buti, Anduela Mjeshtri

Nephrol Dial Transplant· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study.
Alberto Bocchetta, Raffaella Ardau, Paolo Carta, Franca Ligas, Claudia Sardu

BMC Med· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy in a kidney transplant patient treated with everolimus.
Paolo Carta, Leonardo Caroti, Maria Zanazzi

Am J Kidney Dis· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study.
Elisabetta Poluzzi, Carlo Piccinni, Paolo Carta, Aurora Puccini, Monica Lanzoni

Eur J Clin Pharmacol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis